CD44 and neoplasm: In agreement with the data in a recent study by Anido et al. [14], immunohistochemistry with the pan-CD44 antibody confirmed that four of these tumors (GBM107, 177, 1600, and 30) contained tumor cells with high expression of pan-CD44 (Fig. 2A, lower left and middle panels).